{"filing":{"accession_number":"0001213900-26-099345","cik":"0001807166","ticker":"AMST","company_name":"Amesite Inc.","form":"8-K","filing_date":"2026-09-11","report_date":"2026-09-11","primary_document":"ea0305346-8k_amesite.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1807166/000121390026099345/ea0305346-8k_amesite.htm"},"events":[{"id":33026,"run_id":30357,"accession_number":"0001213900-26-099345","anchor_item_number":"7.01","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.72,"summary":"Amesite furnished a shareholder update presentation dated September 9, 2026, detailing Q2 2027 business progress including product validation milestones for NurseMagic® and LynkMagic™, customer wins (including a 2,700-patient census deployment), market expansion across healthcare providers and other sectors, and April 2026 capital raise details ($2.6M gross proceeds). The presentation covers operational and strategic developments affecting the company's growth trajectory and market execution.","company_name":"Amesite Inc.","ticker":"AMST","filing_date":"2026-09-11","form":"8-K","submitted_at":null,"items":[{"id":36352,"accession_number":"0001213900-26-099345","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"operational_other","event_domain":"operational","is_material":false,"confidence":0.75,"reasoning":"This Item 7.01 disclosure furnishes presentation materials that management intends to use at the H.C. Wainwright 28th Annual Global Investment Conference (September 14–16, 2026). The materials cover the company's operations, product validation, team, and financial position as of Q2 2027. While the presentation contains operational and strategic information about NurseMagic® and LynkMagic™ products, revenue trends, and capital structure, the disclosure itself is a routine furnishing of investor-conference materials under Regulation FD. This is administrative in nature—a standard practice for public companies presenting at investor conferences—rather than a material event that would change the total mix of information available to investors beyond what would be expected from normal quarterly disclosures and prior 8-K filings (e.g., the May 19, 2026 large enterprise customer announcement already disclosed separately).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-11T21:17:50.262708+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":36352,"accession_number":"0001213900-26-099345","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"operational_other","event_domain":"operational","is_material":false,"confidence":0.75,"reasoning":"This Item 7.01 disclosure furnishes presentation materials that management intends to use at the H.C. Wainwright 28th Annual Global Investment Conference (September 14–16, 2026). The materials cover the company's operations, product validation, team, and financial position as of Q2 2027. While the presentation contains operational and strategic information about NurseMagic® and LynkMagic™ products, revenue trends, and capital structure, the disclosure itself is a routine furnishing of investor-conference materials under Regulation FD. This is administrative in nature—a standard practice for public companies presenting at investor conferences—rather than a material event that would change the total mix of information available to investors beyond what would be expected from normal quarterly disclosures and prior 8-K filings (e.g., the May 19, 2026 large enterprise customer announcement already disclosed separately).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-11T21:17:50.262708+00:00","company_name":"Amesite Inc.","ticker":"AMST","filing_date":"2026-09-11"}]}